Abstract:Over the last few decades, stem cell-based therapy has become a novel strategy for a variety of disorders including cardiovascular, digestive and respiratory diseases. Among the stem cells investigated, mesenchymal stem cells (MSCs) are the ideal candidate cell source due to their many characteristics, including ease of isolation and expansion, multilineage differentiation potential and immunoregulatory function. Nevertheless MSCs derived from aged donors or patients with agerelated diseases are senescent (Shi et al., 2021). In addition, prolonged in vitro expansion induces MSC senescence (Li et al., 2019). Although allogeneic transplantation of MSCs exerts beneficial effects in the early days post-transplantation, long-term benefits compared with those of autologous MSCs are compromised due to sustained immunorejection (Huang et al., 2010). Senescence severely affects the characteristics and function of MSCs, limiting their application in regenerative medicine. Exploring effective strategies to rejuvenate autologous senescent MSC and improve their therapeutic capacity is vital. Although multiple factors including age, oxidative stress and mitochondrial dysfunction have been reported to mediate MSC senescence, the underlying mechanisms of this senescence remain unclear. There are twelve manuscripts in this Research Topic, highlighting the current understanding of the potential mechanisms underlying MSC senescence and novel strategies to rejuvenate the senescent MSC. Liu et al. and Zhou et al. summarize the current knowledge of phenotypic and biological properties of senescent MSCs and strategies for monitoring and rejuvenation, including gene modification and pretreatment strategies (Liu et al.; Zhou et al.). They also systematically review the molecular mechanisms underlying MSC senescence including epigenetic changes, autophagy, mitochondrial dysfunction and telomere shortening. There is accumulating evidence that autophagy acts as a positive and negative regulator of MSC senescence (Ma et al., 2018; Yang et al., 2018). Rastaldo et al. discuss these conflicting roles of autophagy in MSC senescence and potential mechanistic explanations for such an intricate liaison (Rastaldo et al.). Sirtuin 3 (SIRT3), an NAD + -dependent deacetylase, regulates a variety of physiological and pathological processes including aging and aging-related diseases. Ma et al. have shown that reduced Sirt3 expression contributes to age-related natural senescence and H2O2-induced premature senescence of rat bone marrow (BM)-MSCs by stimulating cellular reactive oxygen species (ROS) production and DNA injury (Ma et al.). Overexpressing Sirt3 partly reversed the senescence-associated phenotypic features of natural and premature senescent MSCs by alleviating ROS generation and upregulating SOD2 expression. Qin et al. reveal that knockout of NO synthase 2 significantly promoted the adipogenic, but not osteogenic, differentiation capacity of rat MSCs (Qin et al.). Notably, they also showed that knockout of NOS2 in MSCs resulted in significant obesity in rat fed a high-fat diet. Edited by: Atsushi Asakura, University of Minnesota Twin Cities, United States

Resveratrol attenuates senescence of adipose-derived mesenchymal stem cells and restores their paracrine effects on promoting insulin secretion of INS-1 cells through Pim-1

[Effects of Resveratrol on Aging of Mesenchymal Stem Cells and Its Mechanism].

GW24-e2135 SIRT1 Significantly Influences Old Sourced MSCs Aging and Proliferation

Autophagy inhibits the mesenchymal stem cell aging induced by D-galactose through ROS/JNK/p38 signalling

SIRT1 Ameliorates Age-Related Senescence of Mesenchymal Stem Cells Via Modulating Telomere Shelterin

S-adenosyl-L-methionine alleviates the senescence of MSCs through the PI3K/AKT/FOXO3a signaling pathway

Ameliorative effects of mesenchymal stromal cells on senescence associated phenotypes in naturally aged rats

Adipose-derived stem cells regulate metabolic homeostasis and delay aging by promoting mitophagy

Counteracting diabetes-induced adipose tissue derived-stromal cell senescence

SIRT1 reverses senescence via enhancing autophagy and attenuates oxidative stress-induced apoptosis through promoting p53 degradation

SIRT1 is Required for Long-Term Growth of Human Mesenchymal Stem Cells.

Mesenchymal stem cells alleviate aging in vitro and in vivo

Curcumin Affects Adipose Tissue-Derived Mesenchymal Stem Cell Aging Through TERT Gene Expression

Editorial: Mesenchymal Stem Cell Senescence and Rejuvenation

A senescent model of human adipose-derived stem cells induced by mitomycin

Postprandial triglyceride-rich lipoproteins-induced premature senescence of adipose-derived mesenchymal stem cells via the SIRT1/p53/Ac-p53/p21 axis through oxidative mechanism

Transcriptome and lipidome profile of human mesenchymal stem cells with reduced senescence and increased trilineage differentiation ability upon drug treatment

Decreased Mir-17-92 Cluster Correlates with Senescence Features, Disrupted Oxidative Homeostasis, and Impaired Therapeutic Efficacy of Mesenchymal Stem Cells

Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.

Ohwia caudata aqueous extract attenuates senescence in aging adipose-derived mesenchymal stem cells

Photomodulation alleviates cellular senescence of aging adipose-derived stem cells